- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 14226
10-year publication summary
|
1062
|
1156
|
1082
|
1176
|
1161
|
1136
|
1002
|
962
|
927
|
876
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10674 |
144 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 287 |
137 |
| Fertin Pharma A/S | 255 |
107 |
| Antecip Bioventures II LLC | 342 |
105 |
| Boehringer Ingelheim International GmbH | 4649 |
97 |
| Axsome Therapeutics, Inc. | 276 |
93 |
| Takeda Pharmaceutical Company Limited | 2713 |
88 |
| ratiopharm GmbH | 300 |
83 |
| Synthon BV | 315 |
77 |
| Daiichi Sankyo Company, Limited | 1881 |
76 |
| Merck Patent GmbH | 5777 |
71 |
| Purdue Pharma L.P. | 496 |
70 |
| Hanmi Pharm. Co., Ltd. | 574 |
67 |
| Vertex Pharmaceuticals Incorporated | 1626 |
65 |
| Gilead Sciences, Inc. | 2065 |
64 |
| AstraZeneca AB | 2853 |
60 |
| Novo Nordisk A/S | 2273 |
60 |
| Hoffmann-La Roche Inc. | 3511 |
57 |
| Astellas Pharma Inc. | 1065 |
53 |
| Lupin Limited | 432 |
53 |
| Other owners | 12599 |